lobular neoplasia

I usually screen with that patients who have dense breasts, but not a lot of other risk factors, some family history.

So those are some of the activities, you know, ADH, LCIS, those are good patients to screen with that.

When we get to the mutation carriers or some other situations, I think MRI still or more frequent screening is indicated because we see interval cancers.

So if we wait a whole year, we may have

So I discovered this in 2004 through surgical biopsy, but had been tracking it for about 18 months prior to that.

They found it in a mammogram and And it was called LCIS, lobular carcinoma in situ, which is now considered, it's been recategorized as a stage zero cancer.

So they don't really treat it as a cancer.

They monitor it and watch it.

What was your decision process

inside like? So because I had had the lymph node removed and it was just one lymph node, they didn't find it anywhere else, I had the choice.

I didn't have to do the double mastectomy, but because I had lobular carcinoma in situ, LCIS, there was a high chance, like 50% chance that it would return in the same breast or in the other breast.

And I would just have to continue with the MRIs and all of the testing for the rest of my life.

And which I thought was so helpful, right? It's almost like an algorithm that she...

You can go through and take a look at, like, if the person had DCIS or if they had, you know, LCIS, and then what kind of therapy that they can have, and what's the data say, and stuff like that.

So what do you use when you are, let's say, counseling a patient or talking to them about their future risks or whether or not they're able to get hormones?

Yeah, absolutely.

There's also lobular carcinoma in situ, which is early kind of pre-cancerous changes that are combi- confined to the lobules of the breast.

Um, and LCIS, lobular, and DCIS, ductal, are different.

When we say stage zero, we're talking about ductal carcinoma in situ.

And in the book, I really go through how to think about them and how we approach the different treatment, um, because the treatments are different.